Coya Therapeutics Files Initial Ownership Statement
Ticker: COYA · Form: 3 · Filed: 2026-04-09T18:42:43-04:00
Sentiment: neutral
Topics: insider-filing, ownership, disclosure
TL;DR
COYA filed initial ownership docs 4/9/26 - new big holders incoming?
AI Summary
On April 9, 2026, Coya Therapeutics, Inc. filed a Form 3, an initial statement of beneficial ownership of securities. This filing indicates the initial reporting of ownership for certain individuals or entities related to the company. The filing was accepted on the same date.
Why It Matters
This filing marks the initial disclosure of beneficial ownership of securities for Coya Therapeutics, Inc., providing transparency for investors regarding who holds significant stakes in the company.
Risk Assessment
Risk Level: low — A Form 3 filing is a standard initial disclosure and does not inherently indicate increased risk.
Key Players & Entities
- Coya Therapeutics, Inc. (company) — Issuer
- Pavao Mark H (person) — Reporting Person
- 0001835022 (company) — CIK for Coya Therapeutics, Inc.
- 0001297988 (person) — CIK for Pavao Mark H
FAQ
What type of filing is this?
This is a Form 3, an initial statement of beneficial ownership of securities.
When was the filing accepted?
The filing was accepted on April 9, 2026.
What is the CIK for Coya Therapeutics, Inc.?
The CIK for Coya Therapeutics, Inc. is 0001835022.
What is the business address of Coya Therapeutics, Inc.?
The business address is 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024.
What is the SIC code for Coya Therapeutics, Inc.?
The SIC code is 2834, Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 0001193125-26-149960 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 3 - Initial statement of beneficial ownership of securities: SEC Accession No. 0001193125-26-149960 Filing Date 2026-04-09 Accepted 2026-04-09 18:42:43 Documents 2 Period of Report 2026-04-01 Document Format Files Seq Description Document Type Size 1 3 ownership.html 3 1 3 ownership.xml 3 1638 2 EX-24 coya-ex24.htm EX-24 11911 Complete submission text file 0001193125-26-149960.txt 14991 Mailing Address C/O NITROMED INC 125 SPRING STREET LEXINGTON MA 02421 Business Address Pavao Mark H ( Reporting ) CIK : 0001297988 (see all company filings) Fiscal Year End: 1231 Type: 3 | Act: 34 | File No.: 001-41583 | Film No.: 26852784 Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939 Coya Therapeutics, Inc. ( Issuer ) CIK : 0001835022 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)